News

Vektor Medical Secures $16 Million Series A Funding
February 5, 2024

Vektor Medical Secures $16 Million Series A Funding

Vektor Medical today announced a $16 million Series A investment co-led by Solas BioVentures and TVM Capital Life Science. This funding underscores investor confidence in Vektor’s vision and ability to successfully execute its mission to revolutionize arrhythmia care.

Funding will support the commercialization of vMap, which is transforming how EPs approach ablation procedures. To bolster this expansion, Vektor will increase clinical support and drive additional clinical studies to showcase the technology’s impact and inform future innovation as well as continue efforts to secure reimbursement.

Background image of a crowd watching a presentation on stageBackground image of a well lit office spaceBackground image of abstract, dimensional, curvy linesBackground image of abstract blue transparent shapesBackground image of a clinic waiting room
No items found.